Loading clinical trials...
Loading clinical trials...
Follow-Up Study to Assess Long-Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies
Conditions
Interventions
Retosiban
Atosiban
+1 more
Locations
26
United States
GSK Investigational Site
Park Ridge, Illinois, United States
GSK Investigational Site
Galveston, Texas, United States
GSK Investigational Site
Ghent, Belgium
GSK Investigational Site
Freiburg im Breisgau, Baden-Wurttemberg, Germany
GSK Investigational Site
Jena, Germany
GSK Investigational Site
Hadera, Israel
Start Date
June 1, 2015
Primary Completion Date
September 2, 2019
Completion Date
September 2, 2019
Last Updated
July 9, 2020
NCT02377466
NCT02377414
Lead Sponsor
GlaxoSmithKline
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions